Reaction Details |
| Report a problem with these data |
Target | Receptor-interacting serine/threonine-protein kinase 1 |
---|
Ligand | BDBM423389 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Enzyme Immuno Assay |
---|
IC50 | 360±n/a nM |
---|
Citation | Kim, E; Yoo, S; Kang, NS; Koo, T; Park, M; Kim, Y; Bae, H; Kim, J; In, T; Joo, C Fused heterocyclic ring compounds and method of treating retinal disease using same US Patent US10501473 Publication Date 12/10/2019 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Receptor-interacting serine/threonine-protein kinase 1 |
---|
Name: | Receptor-interacting serine/threonine-protein kinase 1 |
Synonyms: | Cell death protein RIP | RIP | RIP-1 | RIP1 | RIPK1 | RIPK1_HUMAN | Receptor-interacting protein 1 |
Type: | Enzyme Catalytic Domain |
Mol. Mass.: | 75926.99 |
Organism: | Homo sapiens (Human) |
Description: | Q13546 |
Residue: | 671 |
Sequence: | MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEAL
LEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIIL
EIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVD
GTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMC
IKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEED
VKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFA
PSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPF
AQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLD
PGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQ
IGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKN
CARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRID
LLSSLIYVSQN
|
|
|
BDBM423389 |
---|
n/a |
---|
Name | BDBM423389 |
Synonyms: | US10501473, Example 35 |
Type | Small organic molecule |
Emp. Form. | C19H16FNOS |
Mol. Mass. | 325.4 |
SMILES | Fc1ccc(cc1)-c1cccc2sc(cc12)C(=O)N1CCCC1 |
Structure |
|